Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.81 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.117 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.118 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.27 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.617.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.67 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.110 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.39.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.20 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.42 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.62 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.113 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.43 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.98.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.127 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.83 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
XBB.1.16.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.2.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EU.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.4.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.59NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.24.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.17.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.63NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.2.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GW.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.2.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.14.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.13.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HL.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.42.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DZ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DZ.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.14.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DY.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used